1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Oncology Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Chemotherapy Medication
  • 1.2.3 Targeted Therapy Medication
  • 1.2.4 Immunotherapy Medication
  • 1.2.5 Hormonal Therapy Medication
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Oncology Medication Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Blood Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Gastrointestinal Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Respiratory or Lung Cancer
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology Medication Market Perspective (2016-2027)
• 2.2 Oncology Medication Growth Trends by Regions
  • 2.2.1 Oncology Medication Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Oncology Medication Historic Market Share by Regions (2016-2021)
  • 2.2.3 Oncology Medication Forecasted Market Size by Regions (2022-2027)
• 2.3 Oncology Medication Industry Dynamic
  • 2.3.1 Oncology Medication Market Trends
  • 2.3.2 Oncology Medication Market Drivers
  • 2.3.3 Oncology Medication Market Challenges
  • 2.3.4 Oncology Medication Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Medication Players by Revenue
  • 3.1.1 Global Top Oncology Medication Players by Revenue (2016-2021)
  • 3.1.2 Global Oncology Medication Revenue Market Share by Players (2016-2021)
• 3.2 Global Oncology Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Oncology Medication Revenue
• 3.4 Global Oncology Medication Market Concentration Ratio
  • 3.4.1 Global Oncology Medication Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Medication Revenue in 2020
• 3.5 Oncology Medication Key Players Head office and Area Served
• 3.6 Key Players Oncology Medication Product Solution and Service
• 3.7 Date of Enter into Oncology Medication Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Medication Breakdown Data by Type

• 4.1 Global Oncology Medication Historic Market Size by Type (2016-2021)
• 4.2 Global Oncology Medication Forecasted Market Size by Type (2022-2027)

5 Oncology Medication Breakdown Data by Application

• 5.1 Global Oncology Medication Historic Market Size by Application (2016-2021)
• 5.2 Global Oncology Medication Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Oncology Medication Market Size (2016-2027)
• 6.2 North America Oncology Medication Market Size by Type
  • 6.2.1 North America Oncology Medication Market Size by Type (2016-2021)
  • 6.2.2 North America Oncology Medication Market Size by Type (2022-2027)
  • 6.2.3 North America Oncology Medication Market Size by Type (2016-2027)
• 6.3 North America Oncology Medication Market Size by Application
  • 6.3.1 North America Oncology Medication Market Size by Application (2016-2021)
  • 6.3.2 North America Oncology Medication Market Size by Application (2022-2027)
  • 6.3.3 North America Oncology Medication Market Size by Application (2016-2027)
• 6.4 North America Oncology Medication Market Size by Country
  • 6.4.1 North America Oncology Medication Market Size by Country (2016-2021)
  • 6.4.2 North America Oncology Medication Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Oncology Medication Market Size (2016-2027)
• 7.2 Europe Oncology Medication Market Size by Type
  • 7.2.1 Europe Oncology Medication Market Size by Type (2016-2021)
  • 7.2.2 Europe Oncology Medication Market Size by Type (2022-2027)
  • 7.2.3 Europe Oncology Medication Market Size by Type (2016-2027)
• 7.3 Europe Oncology Medication Market Size by Application
  • 7.3.1 Europe Oncology Medication Market Size by Application (2016-2021)
  • 7.3.2 Europe Oncology Medication Market Size by Application (2022-2027)
  • 7.3.3 Europe Oncology Medication Market Size by Application (2016-2027)
• 7.4 Europe Oncology Medication Market Size by Country
  • 7.4.1 Europe Oncology Medication Market Size by Country (2016-2021)
  • 7.4.2 Europe Oncology Medication Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Oncology Medication Market Size (2016-2027)
• 8.2 Asia-Pacific Oncology Medication Market Size by Type
  • 8.2.1 Asia-Pacific Oncology Medication Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Oncology Medication Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Oncology Medication Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Oncology Medication Market Size by Application
  • 8.3.1 Asia-Pacific Oncology Medication Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Oncology Medication Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Oncology Medication Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Oncology Medication Market Size by Region
  • 8.4.1 Asia-Pacific Oncology Medication Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Oncology Medication Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Oncology Medication Market Size (2016-2027)
• 9.2 Latin America Oncology Medication Market Size by Type
  • 9.2.1 Latin America Oncology Medication Market Size by Type (2016-2021)
  • 9.2.2 Latin America Oncology Medication Market Size by Type (2022-2027)
  • 9.2.3 Latin America Oncology Medication Market Size by Type (2016-2027)
• 9.3 Latin America Oncology Medication Market Size by Application
  • 9.3.1 Latin America Oncology Medication Market Size by Application (2016-2021)
  • 9.3.2 Latin America Oncology Medication Market Size by Application (2022-2027)
  • 9.3.3 Latin America Oncology Medication Market Size by Application (2016-2027)
• 9.4 Latin America Oncology Medication Market Size by Country
  • 9.4.1 Latin America Oncology Medication Market Size by Country (2016-2021)
  • 9.4.2 Latin America Oncology Medication Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Oncology Medication Market Size (2016-2027)
• 10.2 Middle East & Africa Oncology Medication Market Size by Type
  • 10.2.1 Middle East & Africa Oncology Medication Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Oncology Medication Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Oncology Medication Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Oncology Medication Market Size by Application
  • 10.3.1 Middle East & Africa Oncology Medication Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Oncology Medication Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Oncology Medication Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Oncology Medication Market Size by Country
  • 10.4.1 Middle East & Africa Oncology Medication Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Oncology Medication Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Roche
  • 11.1.1 Roche Company Details
  • 11.1.2 Roche Business Overview
  • 11.1.3 Roche Oncology Medication Introduction
  • 11.1.4 Roche Revenue in Oncology Medication Business (2016-2021)
  • 11.1.5 Roche Recent Development
• 11.2 Celgene
  • 11.2.1 Celgene Company Details
  • 11.2.2 Celgene Business Overview
  • 11.2.3 Celgene Oncology Medication Introduction
  • 11.2.4 Celgene Revenue in Oncology Medication Business (2016-2021)
  • 11.2.5 Celgene Recent Development
• 11.3 Novartis
  • 11.3.1 Novartis Company Details
  • 11.3.2 Novartis Business Overview
  • 11.3.3 Novartis Oncology Medication Introduction
  • 11.3.4 Novartis Revenue in Oncology Medication Business (2016-2021)
  • 11.3.5 Novartis Recent Development
• 11.4 Bristol-Myers Squibb
  • 11.4.1 Bristol-Myers Squibb Company Details
  • 11.4.2 Bristol-Myers Squibb Business Overview
  • 11.4.3 Bristol-Myers Squibb Oncology Medication Introduction
  • 11.4.4 Bristol-Myers Squibb Revenue in Oncology Medication Business (2016-2021)
  • 11.4.5 Bristol-Myers Squibb Recent Development
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Company Details
  • 11.5.2 Johnson & Johnson Business Overview
  • 11.5.3 Johnson & Johnson Oncology Medication Introduction
  • 11.5.4 Johnson & Johnson Revenue in Oncology Medication Business (2016-2021)
  • 11.5.5 Johnson & Johnson Recent Development
• 11.6 Merck & Co.
  • 11.6.1 Merck & Co. Company Details
  • 11.6.2 Merck & Co. Business Overview
  • 11.6.3 Merck & Co. Oncology Medication Introduction
  • 11.6.4 Merck & Co. Revenue in Oncology Medication Business (2016-2021)
  • 11.6.5 Merck & Co. Recent Development
• 11.7 AstraZeneca
  • 11.7.1 AstraZeneca Company Details
  • 11.7.2 AstraZeneca Business Overview
  • 11.7.3 AstraZeneca Oncology Medication Introduction
  • 11.7.4 AstraZeneca Revenue in Oncology Medication Business (2016-2021)
  • 11.7.5 AstraZeneca Recent Development
• 11.8 Pfizer
  • 11.8.1 Pfizer Company Details
  • 11.8.2 Pfizer Business Overview
  • 11.8.3 Pfizer Oncology Medication Introduction
  • 11.8.4 Pfizer Revenue in Oncology Medication Business (2016-2021)
  • 11.8.5 Pfizer Recent Development
• 11.9 Amgen
  • 11.9.1 Amgen Company Details
  • 11.9.2 Amgen Business Overview
  • 11.9.3 Amgen Oncology Medication Introduction
  • 11.9.4 Amgen Revenue in Oncology Medication Business (2016-2021)
  • 11.9.5 Amgen Recent Development
• 11.10 Takeda
  • 11.10.1 Takeda Company Details
  • 11.10.2 Takeda Business Overview
  • 11.10.3 Takeda Oncology Medication Introduction
  • 11.10.4 Takeda Revenue in Oncology Medication Business (2016-2021)
  • 11.10.5 Takeda Recent Development
• 11.11 Astellas
  • 11.11.1 Astellas Company Details
  • 11.11.2 Astellas Business Overview
  • 11.11.3 Astellas Oncology Medication Introduction
  • 11.11.4 Astellas Revenue in Oncology Medication Business (2016-2021)
  • 11.11.5 Astellas Recent Development
• 11.12 Ipsen
  • 11.12.1 Ipsen Company Details
  • 11.12.2 Ipsen Business Overview
  • 11.12.3 Ipsen Oncology Medication Introduction
  • 11.12.4 Ipsen Revenue in Oncology Medication Business (2016-2021)
  • 11.12.5 Ipsen Recent Development
• 11.13 Sanofi
  • 11.13.1 Sanofi Company Details
  • 11.13.2 Sanofi Business Overview
  • 11.13.3 Sanofi Oncology Medication Introduction
  • 11.13.4 Sanofi Revenue in Oncology Medication Business (2016-2021)
  • 11.13.5 Sanofi Recent Development
• 11.14 Bayer
  • 11.14.1 Bayer Company Details
  • 11.14.2 Bayer Business Overview
  • 11.14.3 Bayer Oncology Medication Introduction
  • 11.14.4 Bayer Revenue in Oncology Medication Business (2016-2021)
  • 11.14.5 Bayer Recent Development
• 11.15 Biogen Idec
  • 11.15.1 Biogen Idec Company Details
  • 11.15.2 Biogen Idec Business Overview
  • 11.15.3 Biogen Idec Oncology Medication Introduction
  • 11.15.4 Biogen Idec Revenue in Oncology Medication Business (2016-2021)
  • 11.15.5 Biogen Idec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Oncology Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy Medication
Targeted Therapy Medication
Immunotherapy Medication
Hormonal Therapy Medication
Others

Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Takeda
Astellas
Ipsen
Sanofi
Bayer